Epidemiology of EML4–ALK translocations in a small, German non-small-cell lung cancer patient cohort

Author： Schildgen Verena   Lochi Vincenza   Lüsebrink Jessica   Brockmann Michael   Schildgen Oliver  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.9, Iss.8, 2012-11, pp. : 801-803

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EML4-ALK in non-small-cell lung cancer: the breathtaking progress from benchtop to Phase III clinical trial

By Ku Geoffrey Y   Lima Jopes Jr Gilberto de  

Therapy, Vol. 8, Iss. 1, 2011-01 ,pp. : 55-61

Future Medicine

Access to resources Recommend Favorite

EML4-ALK Rearrangement and Its Clinical Significance in Chinese Patients with Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 83, Iss. 5, 2012-09 ,pp. : 248-256

Karger

Access to resources Recommend Favorite

Molecular Pathology of Non-Small-Cell Lung Cancer

By  

Respiration, Vol. 72, Iss. 3, 2005-06 ,pp. : 313-330

Karger

Access to resources Recommend Favorite

Hycamtin in the Therapy of Non-Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1999-01 ,pp. : 18-21

Karger

Access to resources Recommend Favorite

Current Standards of Care in Small-Cell and Non-Small-Cell Lung Cancer

By  

Oncology, Vol. 61, Iss. 1, 2001-09 ,pp. : 3-13

Karger

Access to resources Recommend Favorite